Literature DB >> 17452478

Modular structure of microcin H47 and colicin V.

María F Azpiroz1, Magela Laviña.   

Abstract

Microcins are gene-encoded peptide antibiotics produced by enterobacteria that act on strains of gram-negative bacteria. In this work, we concentrated on higher-molecular-mass microcins, i.e., those possessing 60 or more amino acids. They can be subdivided into unmodified and posttranslationally modified peptides. In both cases, they exhibit conserved C-terminal sequences that appear to be characteristic of each subgroup. In the hypothesis that these sequences could correspond to domains, gene fusions between the activity genes for the unmodified microcin colicin V and the modified microcin H47 were constructed. These two microcins differ in their mode of synthesis, uptake, target, and specific immunity. Through this experimental approach, chimeric peptides with exchanged C-terminal sequences were encoded. Cells carrying the fusions in different genetic contexts were then assayed for antibiotic production. Many of them produced antibiotic activities with recombinant properties: the toxicity of one microcin and the mode of uptake of the other. The results led to the identification of a modular structure of colicin V and microcin H47, with the recognition of two domains in their peptide chains: a toxic N-terminal domain and an uptake C-terminal domain. This modular design would be shared by other microcins from each subgroup.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452478      PMCID: PMC1913283          DOI: 10.1128/AAC.01606-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  The structure, function, and origin of the microcin H47 ATP-binding cassette exporter indicate its relatedness to that of colicin V.

Authors:  M F Azpiroz; E Rodríguez; M Laviña
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  ATP synthase is necessary for microcin H47 antibiotic action.

Authors:  M Trujillo; E Rodríguez; M Laviña
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 3.  Ton-dependent colicins and microcins: modular design and evolution.

Authors:  Volkmar Braun; Silke I Patzer; Klaus Hantke
Journal:  Biochimie       Date:  2002 May-Jun       Impact factor: 4.079

4.  The proton channel is the minimal structure of ATP synthase necessary and sufficient for microcin h47 antibiotic action.

Authors:  Eliana Rodríguez; Magela Laviña
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

5.  Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone.

Authors:  K Johan Rosengren; Richard J Clark; Norelle L Daly; Ulf Göransson; Alun Jones; David J Craik
Journal:  J Am Chem Soc       Date:  2003-10-15       Impact factor: 15.419

6.  Involvement of enterobactin synthesis pathway in production of microcin H47.

Authors:  María F Azpiroz; Magela Laviña
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

7.  Comparative analysis of chromosome-encoded microcins.

Authors:  María Eloisa Poey; María F Azpiroz; Magela Laviña
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  Bactericidal activity of both secreted and nonsecreted microcin E492 requires the mannose permease.

Authors:  Sylvain Bieler; Filo Silva; Claudio Soto; Dominique Belin
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

9.  Genetic analysis and complete primary structure of microcin L.

Authors:  Anne-Marie Pons; François Delalande; Mariela Duarte; Stéphanie Benoit; Isabelle Lanneluc; Sophie Sablé; Alain Van Dorsselaer; Gilles Cottenceau
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

10.  Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN.

Authors:  K Hantke; G Nicholson; W Rabsch; G Winkelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

View more
  9 in total

1.  Mechanism of bactericidal activity of microcin L in Escherichia coli and Salmonella enterica.

Authors:  Natacha Morin; Isabelle Lanneluc; Nathalie Connil; Marie Cottenceau; Anne Marie Pons; Sophie Sablé
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  Hybrids made from antimicrobial peptides with different mechanisms of action show enhanced membrane permeabilization.

Authors:  Heidi M Wade; Louise E O Darling; Donald E Elmore
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-05-05       Impact factor: 3.747

3.  Biosynthetic tailoring of microcin E492m: post-translational modification affords an antibacterial siderophore-peptide conjugate.

Authors:  Elizabeth M Nolan; Michael A Fischbach; Alexander Koglin; Christopher T Walsh
Journal:  J Am Chem Soc       Date:  2007-10-31       Impact factor: 15.419

4.  A new hybrid bacteriocin, Ent35-MccV, displays antimicrobial activity against pathogenic Gram-positive and Gram-negative bacteria.

Authors:  Leonardo Acuña; Gianluca Picariello; Fernando Sesma; Roberto D Morero; Augusto Bellomio
Journal:  FEBS Open Bio       Date:  2012-01-31       Impact factor: 2.693

5.  pMPES: A Modular Peptide Expression System for the Delivery of Antimicrobial Peptides to the Site of Gastrointestinal Infections Using Probiotics.

Authors:  Kathryn Geldart; Brittany Forkus; Evelyn McChesney; Madeline McCue; Yiannis N Kaznessis
Journal:  Pharmaceuticals (Basel)       Date:  2016-10-05

Review 6.  Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere.

Authors:  Fernando Baquero; Val F Lanza; Maria-Rosario Baquero; Rosa Del Campo; Daniel A Bravo-Vázquez
Journal:  Front Microbiol       Date:  2019-10-09       Impact factor: 5.640

7.  Bacteriocin Occurrence and Activity in Escherichia coli Isolated from Bovines and Wastewater.

Authors:  Andrew Cameron; Rahat Zaheer; Emelia H Adator; Ruth Barbieri; Tim Reuter; Tim A McAllister
Journal:  Toxins (Basel)       Date:  2019-08-15       Impact factor: 4.546

8.  Prevalence of Virulence Genes and Their Association with Antimicrobial Resistance Among Pathogenic E. coli Isolated from Egyptian Patients with Different Clinical Infections.

Authors:  Rehab Mahmoud Abd El-Baky; Reham Ali Ibrahim; Doaa Safwat Mohamed; Eman Farouk Ahmed; Zeinab Shawky Hashem
Journal:  Infect Drug Resist       Date:  2020-04-28       Impact factor: 4.003

9.  Engineered E. coli Nissle 1917 for the reduction of vancomycin-resistant Enterococcus in the intestinal tract.

Authors:  Kathryn G Geldart; Sushma Kommineni; Madeline Forbes; Michael Hayward; Gary M Dunny; Nita H Salzman; Yiannis N Kaznessis
Journal:  Bioeng Transl Med       Date:  2018-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.